Patents by Inventor Olivier Join-Lambert

Olivier Join-Lambert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190389927
    Abstract: The present invention concerns the use of an inhibitor of an interaction between between type IV pilus-associated protein and CD147 for preventing or treating meningoccal bacteraemia and/or infection. The present invention also relates to the combined use of such inhibitor and of an anti-bacterial compound, such as one used to prevent or treat a meningococcal infection. The invention also relates to a method for the prevention and/or treatment of meningococcal bacteraemia and/or infection, and to a method for screening inhibitors of the interaction between type IV pilus-associated protein and CD147.
    Type: Application
    Filed: April 29, 2019
    Publication date: December 26, 2019
    Inventors: Xavier NASSIF, Sandrine BOURDOULOUS, Olivier JOIN-LAMBERT
  • Publication number: 20180340017
    Abstract: The present invention concerns the use of an inhibitor of an interaction between type IV pilus-associated protein and CD147 for preventing or treating meningoccal bacteraemia and/or infection. The present invention also relates to the combined use of such inhibitor and of an anti-bacterial compound, such as one used to prevent or treat a meningococcal infection. The invention also relates to a method for the prevention and/or treatment of meningococcal bacteraemia and/or infection, and to a method for screening inhibitors of the interaction between type IV pilus-associated protein and CD147.
    Type: Application
    Filed: May 25, 2018
    Publication date: November 29, 2018
    Inventors: Xavier NASSIF, Sandrine BOURDOULOUS, Olivier JOIN-LAMBERT
  • Patent number: 10000545
    Abstract: The present invention concerns the use of an inhibitor of an interaction between type IV pilus-associated protein and CD147 for preventing or treating meningoccal bacteraemia and/or infection. The present invention also relates to the combined use of such inhibitor and of an anti-bacterial compound, such as one used to prevent or treat a meningococcal infection. The invention also relates to a method for the prevention and/or treatment of meningococcal bacteraemia and/or infection, and to a method for screening inhibitors of the interaction between type IV pilus-associated protein and CD147.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: June 19, 2018
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PARIS DESCARTES
    Inventors: Xavier Nassif, Sandrine Bourdoulous, Olivier Join-Lambert
  • Publication number: 20150110806
    Abstract: The present invention concerns the use of an inhibitor of an interaction between type IV pilus-associated protein and CD147 for preventing or treating meningoccal bacteraemia and/or infection. The present invention also relates to the combined use of such inhibitor and of an anti-bacterial compound, such as one used to prevent or treat a meningococcal infection. The invention also relates to a method for the prevention and/or treatment of meningococcal bacteraemia and/or infection, and to a method for screening inhibitors of the interaction between type IV pilus-associated protein and CD147.
    Type: Application
    Filed: July 15, 2013
    Publication date: April 23, 2015
    Inventors: Xavier Nassif, Sandrine Bourdoulous, Olivier Join-Lambert